I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Safety, tolerability and clinical implementation of 'ready-..:
Manoharan, Prakash
;
Lamarca, Angela
;
Navalkissoor, S
...
Manoharan , P , Lamarca , A , Navalkissoor , S , Calero , J , Chan , P S , Julyan , P J , Sierra , M L , Caplin , M & Valle , J 2020 , ' Safety, tolerability and clinical implementation of 'ready-to-use ' (68)gallium-DOTA0-Tyr3-octreotide (Ga-68-DOTATOC) (SomaKIT TOC) for injection in patients diagnosed with gastroenteropancreatic neuroendocrine tumours (GEP-NETs) ' , ESMO Open , vol. 5 , no. 2 , e000650 . https://doi.org/10.1136/esmoopen-2019-000650. , 2020
Link:
https://research.manchester.ac.uk/en/publications/04cb..
RT Journal T1
Safety, tolerability and clinical implementation of 'ready-to-use' (68)gallium-DOTA0-Tyr3-octreotide (Ga-68-DOTATOC) (SomaKIT TOC) for injection in patients diagnosed with gastroenteropancreatic neuroendocrine tumours (GEP-NETs)
UL https://suche.suub.uni-bremen.de/peid=base-ftumanchesterpub:oai:pure.atira.dk:publications_04cb2518-ae8a-4d93-a4b2-26d00ef158ca&Exemplar=1&LAN=DE A1 Manoharan, Prakash A1 Lamarca, Angela A1 Navalkissoor, S A1 Calero, J A1 Chan, P S A1 Julyan, P J A1 Sierra, M Lopera A1 Caplin, M A1 Valle, Juan YR 2020 K1 PET K1 SomaKIT-TOC K1 gallium K1 imaging K1 neuroendocrine K1 ResearchInstitutes_Networks_Beacons/mcrc K1 Manchester Cancer Research Centre JF Manoharan , P , Lamarca , A , Navalkissoor , S , Calero , J , Chan , P S , Julyan , P J , Sierra , M L , Caplin , M & Valle , J 2020 , ' Safety, tolerability and clinical implementation of 'ready-to-use ' (68)gallium-DOTA0-Tyr3-octreotide (Ga-68-DOTATOC) (SomaKIT TOC) for injection in patients diagnosed with gastroenteropancreatic neuroendocrine tumours (GEP-NETs) ' , ESMO Open , vol. 5 , no. 2 , e000650 . https://doi.org/10.1136/esmoopen-2019-000650 LK http://dx.doi.org/https://research.manchester.ac.uk/en/publications/04cb2518-ae8a-4d93-a4b2-26d00ef158ca DO https://research.manchester.ac.uk/en/publications/04cb2518-ae8a-4d93-a4b2-26d00ef158ca SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)